Cargando…

Metallopeptidase inhibitor 1 (TIMP‐1) promotes receptor tyrosine kinase c‐Kit signaling in colorectal cancer

Colorectal cancer (CRC) is the third most prevalent cancer worldwide causing an estimated 700 000 deaths annually. Different types of treatment are available for patients with advanced metastatic colorectal cancer, including targeted biological agents, such as cetuximab, a monoclonal antibody that t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nordgaard, Cathrine, Doll, Sophia, Matos, Ana Laura de Souza Almeida, Høeberg, Mikkel, Uddin Kazi, Julhash, Friis, Stine, Stenvang, Jan, Rönnstrand, Lars, Mann, Matthias, Manuel Afonso Moreira, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887592/ https://www.ncbi.nlm.nih.gov/pubmed/31545548 http://dx.doi.org/10.1002/1878-0261.12575

Ejemplares similares

Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012)

Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication
por: Lorenc, Zbigniew, et al.
Publicado: (2017)

SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
por: Rupar, Kaja, et al.
Publicado: (2018)

The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells
por: Høeberg, Mikkel, et al.
Publicado: (2023)

A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
por: Nasimian, Ahmad, et al.
Publicado: (2023)

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
por: Marhäll, Alissa, et al.
Publicado: (2017)

FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
por: Chougule, Rohit A., et al.
Publicado: (2016)

Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2023)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients
por: Aaberg-Jessen, Charlotte, et al.
Publicado: (2016)

Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2017)

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

Expression of GADS enhances FLT3-induced mitogenic signaling
por: Chougule, Rohit A., et al.
Publicado: (2016)

BEX1 acts as a tumor suppressor in acute myeloid leukemia
por: Lindblad, Oscar, et al.
Publicado: (2015)

Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study
por: Thorsen, Stine B, et al.
Publicado: (2013)

The role of multifunctional M1 metallopeptidases in cell cycle progression
por: Peer, Wendy Ann
Publicado: (2011)

Structural and evolutionary insights into astacin metallopeptidases
por: Gomis-Rüth, F. Xavier, et al.
Publicado: (2023)

Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
por: Moharram, Sausan A., et al.
Publicado: (2016)

Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019)

Matrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis
por: Szóstek-Mioduchowska, Anna, et al.
Publicado: (2020)

Metallopeptidases of Toxoplasma gondii: in silico identification and gene expression
por: Escotte-Binet, Sandie, et al.
Publicado: (2018)

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas
por: Groft, L L, et al.
Publicado: (2001)

Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors
por: ZURAC, SABINA, et al.
Publicado: (2016)

TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients
por: Briggs, Esther L. Ashworth, et al.
Publicado: (2015)

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
por: Kazi, Julhash U.
Publicado: (2020)

The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness
por: Zhang, Jing, et al.
Publicado: (2015)

Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults
por: Yu, A. P., et al.
Publicado: (2015)

Hydroxytyrosol Supplementation Modifies Plasma Levels of Tissue Inhibitor of Metallopeptidase 1 in Women with Breast Cancer
por: Ramirez-Tortosa, Cesar, et al.
Publicado: (2019)

C-KIT Signaling Depends on Microphthalmia-Associated Transcription Factor for Effects on Cell Proliferation
por: Phung, Bengt, et al.
Publicado: (2011)

p63 transcriptionally regulates the expression of matrix metallopeptidase 13
por: Celardo, Ivana, et al.
Publicado: (2014)

Localised release of matrix metallopeptidase 8 in fatal cerebral malaria
por: Georgiadou, Athina, et al.
Publicado: (2021)

Zymogenic latency in an ∼250-million-year-old astacin metallopeptidase
por: Guevara, Tibisay, et al.
Publicado: (2022)

P479: TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K
por: Falqués-Costa, Ton, et al.
Publicado: (2023)

TIMP-1, TIMP-2 and MMP-9 as prognostic markers for clinical outcome in sepsis
por: Hoffmann, U, et al.
Publicado: (2003)

Fra-1 regulation of Matrix Metallopeptidase-1 (MMP-1) in metastatic variants of MDA-MB-231 breast cancer cells
por: Henckels, Eric, et al.
Publicado: (2013)

Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer
por: CHEN, JING, et al.
Publicado: (2015)

The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity
por: Dimic-Janjic, Sanja, et al.
Publicado: (2023)

XK-related protein 5 (XKR5) is a novel negative regulator of KIT/D816V-mediated transformation
por: Sun, Jianmin, et al.
Publicado: (2018)

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
por: Nasimian, Ahmad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ip2fnffvd1676auesri598accn